Published 12 hours ago • loading... • Updated 12 hours ago

Hikma confirms 2025 guidance and updates medium-term growth outlook

Summary by Zawya

Global Injectables business is trading in line with the expectations set out in August

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

GNN Liberia

Hikma confirms 2025 guidance and updates medium-term growth outlook - Global News Network Liberia

Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading. We are making good progress in the second half, as we have continued to launch products, sign partnerships and execute expansion projects across our global manufacturing footprint. Injectables Our global Injectables business is trading in line with the expectations set out in August. We have seen the expected pick-up in…

12 hours ago·Monrovia, Liberia

Read Full Article